Editorial: Addressing tuberculosis infection: an essential step in the fight against tuberculosis

Miguel Santin; Anete Trajman; Delia Goletti; Luis Anibarro

doi:10.3389/fmed.2024.1428677

Editorial: Addressing tuberculosis infection: an essential step in the fight against tuberculosis

Front Med (Lausanne). 2024 Jun 7:11:1428677. doi: 10.3389/fmed.2024.1428677. eCollection 2024.

Authors

Miguel Santin^#^{1

2

3}, Anete Trajman^#^{4

5

6}, Delia Goletti^#⁷, Luis Anibarro^#^{8

9}

Affiliations

¹ Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
² Department of Clinical Sciences, School of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Ministerio de Ciencia Innovación y Universidades, Madrid, Spain.
⁴ Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁵ McGill TB International Centre, McGill University, Montreal, QC, Canada.
⁶ Rede Brasileira de Pesquisa em Tuberculose, REDE-TB, Rio de Janeiro, Brazil.
⁷ Translational Research Unit, Department of Epidemiology, Istituto Nazionale per le Malattie Infettive L. Spallanzani-IRCCS, Rome, Italy.
⁸ Unidad de Tuberculosis, Enfermedades Infecciosas, Medicina Interna, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
⁹ Immunology Study Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.

^# Contributed equally.

No abstract available

Keywords: End TB Strategy; Mycobacterium tuberculosis; prevention; short rifamycin-based regimens; tuberculosis control; tuberculosis infection; tuberculosis preventive therapy.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AT received a funding from the Brazilian Ministry of Science, Technology and Innovation, CNPq # 301794/2022-7. DG received funding from the Italian Ministry of Health, Ricerca Corrente, Linea 4 progetto 2 and from TBVAC-HORIZON program under Grant No. 101080309. The funders had no impact on any decision-making regarding the manuscript.